Research Article

Acute Kidney Injury and Urinary Sediment Abnormalities in Hospitalized Patients with Coronavirus Disease 2019 (COVID-19) in Morocco

Marouane Jabrane
Ibn Zohr University, Morocco
* Corresponding author
Othmane Benlenda
Ibn Zohr University, Morocco
Laila Lahlou
Ibn Zohr University, Morocco
Mohamed Bouchoual
Ibn Zohr University, Morocco
Mohamed Aghrouch
Hassan II Hospital, Morocco
Hicham Nassik
Ibn Zohr University, Morocco
Mohamed Arrayhani
, Ibn Zohr University, Morocco
DOI icon 10.24018/ejmed.2023.5.1.1589

Read Counter
543

Downloads
399

Citations

Share

Article Sidebar

Submitted 2022-11-12
Published 2023-01-25

Read counter = 543 times

Table of Contents

Article Main Content

Background: The novel coronavirus disease COVID-19 targets mainly the respiratory system, but may in severe cases affect other organs, causing, multiorgan damage, including cardiac injury and acute kidney injury (AKI). The aim of study was to determine the prevalence of AKI and urinary sediment abnormalities in patients with COVID-19 and evaluate the associated factors and outcomes in hospitalized patients.

Material and Methods: All laboratory-confirmed COVID-19 admitted to the hospital during this period were involved in the study from 1st of July to the 1st of August 2020. Patients were subjected to Kidney function tests (KFT) and complete urine analysis.

Results: Eighty-six COVID-19 patients were included in the present study. The median age of the patients was 43,29 years, and 53,5 % were males. AKI developed in 17 patients (19,8%). Of these, 23,5% required renal replacement therapy (RRT), and 13,9 % patients died. 45 (51.7%) patients displayed abnormality in urinalysis, such as proteinuria, hematuria, leukocyturia and or urinary urothelial cell. Elderly patients, patients with associated comorbidities are more commonly affected. Stepwise multivariate logistic regression analyses showed that age (hazard ratio [HR] [95% confidence interval (95%CI)]: 1.006[0.95-1.06], p=0.8], diabetes mellitus (HR [95%CI]: 10,68 [1,78-64], p=0,009) and hyperleucocytosis (HR [95%CI]: 4,63 [1,01-21,1], p=0,04) were independent predictors of AKI.

Conclusion: Kidney dysfunction is common among patients with COVID-19. Patients who develop AKI have bad outcomes this brings us to give more interest in urinalysis and kidney impairment in COVID-19 patients, which should be monitored regularly.

Keywords: Acute kidney injury, COVID-19, proteinuria, SARS-CoV-2

References

  1. Ministry of Health of Morocco (Official Website). [Internet] 2020. [citeed 2021 July 30] Available from: https://www.sante.gov.ma/Pages/Accueil.aspx
     Google Scholar
  2. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020; 395(10223): 497-506
    DOI  |   Google Scholar
  3. Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020; 579: 270-273.
    DOI  |   Google Scholar
  4. Arentz M, Yim E, Klaff L, Lokhandwala S, Riedo FX, Chong M, et al. Characteristics and Outcomes of 21 Critically Ill Patients With COVID-19 in Washington State. JAMA. 2020; 323(16): 1612-1614.
    DOI  |   Google Scholar
  5. Kolhe NV, Fluck RJ, Selby NM, Taal MW. Acute kidney injury associated with COVID-19: A retrospective cohort study. PLoS Med. 2020; 17(10): e1003406.
    DOI  |   Google Scholar
  6. Cheng Y, Luo R, Wang K, Zhang M, Wang Z, Dong L, et al. Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney International. 2020.
    DOI  |   Google Scholar
  7. Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. Jama. 2020; 323(11): 1061-1069.
    DOI  |   Google Scholar
  8. Diao B, Wang C, Wang R, Feng Z, Zhang J, Yang H, et al. Human kidney is a target for novel severe acute respiratory syndrome coronavirus 2 infection. Nat Commun. 2021; 12(1): 2506.
    DOI  |   Google Scholar
  9. Ronco C, Reis T. Kidney involvement in COVID-19 and rationale for extracorporeal therapies. Nat Rev Nephrol. 2020; 16(6): 308‑10.
    DOI  |   Google Scholar
  10. Silversides JA, Major E, Ferguson AJ, Mann EE, McAuley DF, Marshall JC, et al. Conservative fluid management or deresuscitation for patients with sepsis or acute respiratory distress syndrome following the resuscitation phase of critical illness: a systematic review and meta-analysis. Intensive Care Med. 2017; 43(2): 155‑70.
    DOI  |   Google Scholar
  11. Acute Kidney Injury (AKI)-KDIGO. [Internet] [cited 2020 May 2] Available from: https://kdigo.org/guidelines/acute-kidney-injury/
     Google Scholar
  12. Chaudhri I, Moffitt R, Taub E, Annadi RR, Hoai M, Bolotova O, et al. Association of Proteinuria and Hematuria with Acute Kidney Injury and Mortality in Hospitalized Patients with COVID-19. Kidney Blood Press Res. 2020; 11716: 1018-1032.
    DOI  |   Google Scholar
  13. Basu RK, Wheeler DS. Kidney-lung crosstalk and acute kidney injury. Pediatr Nephrol. 2013; 28(12): 2239- 48.
    DOI  |   Google Scholar
  14. Alsaad KO, Hajeer AH, Al Balwi M, Al Moaiqel M, Al Oudah N, Al Ajlan A, et al. Histopathology of Middle East respiratory syndrome coronavirus (MERS-CoV) infection-clinicopathological and ultrastructural study. Histopathology. 2018; 72: 516-524.
    DOI  |   Google Scholar
  15. Peerapornratana S, Manrique-Caballero CL, Gómez H, Kellum JA. Acute kidney injury from sepsis: current concepts, epidemiology, pathophysiology, prevention and treatment. Kidney Int. 2019; 96(5): 1083‑99.
    DOI  |   Google Scholar
  16. Menachery VD, Yount BL Jr, Debbink K, Agnihothram S, Gralinski LE, Plante JA, et al. A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence. Nat Med. 2016; 22: 446.
    DOI  |   Google Scholar
  17. Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020; 382(18): 1708-1720.
    DOI  |   Google Scholar
  18. Yang X, Yu Y, Xu J, Shu H, Liu H, Wu Y, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020; 8(5): 475-481.
    DOI  |   Google Scholar
  19. Li Z, Wu M, Yao J, Guo J, Liao X, Song S, et al. Caution on kidney dysfunctions of 2019-nCoV patients. medRxiv. 2020.
    DOI  |   Google Scholar
  20. Cao M, Zhang D, Wang Y, Lu Y, Zhu X, Li Y, et al. Clinical features of patients infected with the 2019 novel coronavirus (COVID-19) in Shanghai, China. medRxiv. 2020.
    DOI  |   Google Scholar
  21. Martinez-Rojas MA, Vega-Vega O, Bobadilla NA. Is the kidney a target of SARS-CoV-2?. Am J Physiol Renal Physiol. 2020; 318(6): F1454-F1462.
    DOI  |   Google Scholar
  22. Kissling S, Rotman S, Gerber C, Halfon M, Lamoth F, Comte D, et al. Collapsing glomerulopathy in a COVID-19 patient. Kidney Int. 2020; 98(1): 228-231.
    DOI  |   Google Scholar
  23. Larsen CP, Bourne TD, Wilson JD, Saqqa O, Sharshir MA. Collapsing Glomerulopathy in a Patient With COVID-19. Kidney Int Rep. 2020; 5(6): 935-939.
    DOI  |   Google Scholar
  24. Nguyen MT, Maynard SE, Kimmel PL. Misapplications of commonly used kidney equations: renal physiology in practice. Clin J Am Soc Nephrol. 2009; 4(3): 528‑34.
    DOI  |   Google Scholar